Revvity, Inc. (RVTY): Free Cash Flow
$509.41M
Year ended 2025-12-28
$558.11M
Trailing 12 months to 2026-07-05
-5.0%
3-year compound annual growth
-9.3%
5-year compound annual growth
| Period ended | Free Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-28 | $509.41M | -6.0% | 2026-02-24, From 2024-12-30 |
| 2024-12-29 | $541.65M | n/m | 2026-02-24, From 2024-01-01 |
| 2023-12-31 | $9.90M | -98.3% | 2026-02-24, From 2023-01-02 |
| 2023-01-01, Fiscal 2022 | $594.18M | -55.1% | 2025-02-25, From 2022-01-03 |
| 2022-01-02, Fiscal 2021 | $1.32B | +59.9% | 2024-02-27, From 2021-01-04 |
| 2021-01-03, Fiscal 2020 | $828.54M | n/c | 2023-03-01, From 2019-12-30 |
| 2019-12-29 | $287.14M | +31.8% | 2022-03-03, From 2018-12-31 |
| 2018-12-30 | $217.78M | -12.7% | 2021-03-02, From 2018-01-01 |
| 2017-12-31 | $249.36M | -21.8% | 2020-02-25, From 2017-01-02 |
| 2017-01-01, Fiscal 2016 | $318.91M | +23.2% | 2019-02-26, From 2016-01-04 |
| 2016-01-03, Fiscal 2015 | $258.88M | +1.7% | 2018-02-27, From 2014-12-29 |
| 2014-12-28 | $254.44M | n/c | 2017-02-28, From 2013-12-30 |
| 2013-12-29 | $119.61M | +9.0% | 2016-03-01, From 2012-12-31 |
| 2012-12-30 | $109.77M | -43.5% | 2015-02-24, From 2012-01-02 |
| 2012-01-01, Fiscal 2011 | $194.28M | +48.8% | 2014-02-25, From 2011-01-03 |
| 2011-01-02, Fiscal 2010 | $130.61M | +6.0% | 2013-02-26, From 2010-01-04 |
| 2010-01-03, Fiscal 2009 | $123.21M | -32.5% | 2012-02-28, From 2008-12-29 |
| 2008-12-28 | $182.57M | n/a | 2011-03-01, From 2007-12-31 |
Free Cash Flow at similar companies
| Company | Year ended | Free Cash Flow | Change YoY |
|---|---|---|---|
| Revvity, Inc. (RVTY) | 2025-12-28 | $509.41M | -6.0% |
| Bio-Rad Laboratories, Inc. (BIO) | 2025-12-31 | $374.60M | +29.4% |
| Waters Corp (WAT) | 2025-12-31 | $539.81M | -12.9% |
| Bruker Corp (BRKR) | 2025-12-31 | $43.30M | -68.2% |
| Mettler Toledo International Inc (MTD) | 2025-12-31 | $848.65M | -1.8% |
| Illumina, Inc. (ILMN) | 2025-12-28 | $931.00M | +31.3% |
| Avantor, Inc. (AVTR) | 2025-12-31 | $495.00M | -28.5% |
| Agilent Technologies, Inc. (A) | 2025-10-31 | $1.15B | -16.1% |
| 10x Genomics, Inc. (TXG) | 2025-12-31 | $130.12M | n/m |
Compare RVTY, BIO, WAT, BRKR side by side · Screen every company in Laboratory Analytical Instruments ↗